影像组学在胰腺导管腺癌诊疗中的研究进展
Advances in Radiomics for the Diagnosis and Treatment of Pancreatic Ductal Adenocarcinoma
DOI: 10.12677/acm.2025.1572006, PDF,   
作者: 潘炜枫, 肖文波*：浙江大学医学院附属第一医院放射科，浙江 杭州
关键词: 胰腺导管腺癌；影像组学；研究进展；Pancreatic Ductal Adenocarcinoma； Radiomics； Research Advances
摘要: 胰腺导管腺癌(PDAC)是一种恶性程度高、预后极差的消化系统肿瘤，早期诊断困难且传统影像学评估存在主观性强、敏感性不足等局限。影像组学通过提取医学影像中的高通量定量特征并结合机器学习算法，为PDAC的精准诊疗提供了新思路。本文就影像组学在PDAC的诊断及鉴别诊断、生物学行为预测、疗效评估、预后预测等方面的研究进行综述，并展望未来发展方向。
Abstract: Pancreatic Ductal Adenocarcinoma (PDAC) is a highly malignant tumor of the digestive system with an extremely poor prognosis. Early diagnosis remains challenging due to the limitations of conventional imaging, including subjective variability and insufficient sensitivity. Radiomics, by extracting high-throughput quantitative features from medical images and integrating machine learning algo-rithms, provides novel insights for the precision diagnosis and treatment of PDAC. This article reviews the research progress of radiomics in PDAC diagnosis and differential diagnosis, prediction of biological behavior, treatment efficacy evaluation, and prognostic prediction, while also discussing future development directions.
文章引用：潘炜枫, 肖文波. 影像组学在胰腺导管腺癌诊疗中的研究进展[J]. 临床医学进展, 2025, 15(7): 432-440. https://doi.org/10.12677/acm.2025.1572006

参考文献

[1] Yao, L., Zhang, Z., Keles, E., Yazici, C., Tirkes, T. and Bagci, U. (2023) A Review of Deep Learning and Radiomics Approaches for Pancreatic Cancer Diagnosis from Medical Imaging. Current Opinion in Gastroenterology, 39, 436-447. [Google Scholar] [CrossRef] [PubMed]
[2] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[3] Kaczor-Urbanowicz, K.E., Cheng, J., King, J.C., Sedarat, A., Pandol, S.J., Farrell, J.J., et al. (2020) Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers. Pancreas, 49, 1141-1152. [Google Scholar] [CrossRef] [PubMed]
[4] Park, W., Chawla, A. and O’Reilly, E.M. (2021) Pancreatic Cancer. JAMA, 326, 851-862. [Google Scholar] [CrossRef] [PubMed]
[5] Marti-Bonmati, L., Cerdá-Alberich, L., Pérez-Girbés, A., Díaz Beveridge, R., Montalvá Orón, E., Pérez Rojas, J., et al. (2022) Pancreatic Cancer, Radiomics and Artificial Intelligence. The British Journal of Radiology, 95, Article ID: 20220072. [Google Scholar] [CrossRef] [PubMed]
[6] Lee, E.S. (2014) Imaging Diagnosis of Pancreatic Cancer: A State-of-the-Art Review. World Journal of Gastroenterology, 20, 7864-7877. [Google Scholar] [CrossRef] [PubMed]
[7] Yang, Y., Liu, J., Gui, Y., Lei, L. and Zhang, S. (2017) Relationship between Autophagy and Perineural Invasion, Clinicopathological Features, and Prognosis in Pancreatic Cancer. World Journal of Gastroenterology, 23, 7232-7241. [Google Scholar] [CrossRef] [PubMed]
[8] Gillies, R.J., Kinahan, P.E. and Hricak, H. (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology, 278, 563-577. [Google Scholar] [CrossRef] [PubMed]
[9] Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R.G.P.M., Granton, P., et al. (2012) Radiomics: Extracting More Information from Medical Images Using Advanced Feature Analysis. European Journal of Cancer, 48, 441-446. [Google Scholar] [CrossRef] [PubMed]
[10] Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S.A., Schabath, M.B., et al. (2012) Radiomics: The Process and the Challenges. Magnetic Resonance Imaging, 30, 1234-1248. [Google Scholar] [CrossRef] [PubMed]
[11] Rizzo, S., Botta, F., Raimondi, S., Origgi, D., Fanciullo, C., Morganti, A.G., et al. (2018) Radiomics: The Facts and the Challenges of Image Analysis. European Radiology Experimental, 2, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[12] de la Pinta, C. (2022) Radiomics in Pancreatic Cancer for Oncologist: Present and Future. Hepatobiliary & Pancreatic Diseases International, 21, 356-361. [Google Scholar] [CrossRef] [PubMed]
[13] 中华医学会肿瘤分会早诊早治学组. 中华医学会肿瘤学分会胰腺癌早诊早治专家共识[J]. 中华肿瘤杂志, 2020, 42(9): 706-712.
[14] Mukherjee, S., Patra, A., Khasawneh, H., Korfiatis, P., Rajamohan, N., Suman, G., et al. (2022) Radiomics-Based Machine-Learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time before Clinical Diagnosis. Gastroenterology, 163, 1435-1446.e3. [Google Scholar] [CrossRef] [PubMed]
[15] Chu, L.C., Park, S., Kawamoto, S., Fouladi, D.F., Shayesteh, S., Zinreich, E.S., et al. (2019) Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma from Normal Pancreatic Tissue. American Journal of Roentgenology, 213, 349-357. [Google Scholar] [CrossRef] [PubMed]
[16] Wu, L., Cen, C., Yue, X., Chen, L., Wu, H., Yang, M., et al. (2024) A Clinical-Radiomics Nomogram Based on Dual-Layer Spectral Detector CT to Predict Cancer Stage in Pancreatic Ductal Adenocarcinoma. Cancer Imaging, 24, Article No. 55. [Google Scholar] [CrossRef] [PubMed]
[17] Tong, T., Gu, J., Xu, D., Song, L., Zhao, Q., Cheng, F., et al. (2022) Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Images for Assisted Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis. BMC Medicine, 20, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[18] Shen, K., Su, W., Liang, C., Shi, D., Sun, J. and Yu, R. (2024) Differentiating Small (< 2 cm) Pancreatic Ductal Adenocarcinoma from Neuroendocrine Tumors with Multiparametric MRI-Based Radiomic Features. European Radiology, 34, 7553-7563. [Google Scholar] [CrossRef] [PubMed]
[19] Li, J., Liu, F., Fang, X., Cao, K., Meng, Y., Zhang, H., et al. (2022) CT Radiomics Features in Differentiation of Focal-Type Autoimmune Pancreatitis from Pancreatic Ductal Adenocarcinoma: A Propensity Score Analysis. Academic Radiology, 29, 358-366. [Google Scholar] [CrossRef] [PubMed]
[20] Shin, J., Shin, S., Lee, J.H., Song, K.B., Hwang, D.W., Kim, H.J., et al. (2020) Lymph Node Size and Its Association with Nodal Metastasis in Ductal Adenocarcinoma of the Pancreas. Journal of Pathology and Translational Medicine, 54, 387-395. [Google Scholar] [CrossRef] [PubMed]
[21] Bian, Y., Guo, S., Jiang, H., Gao, S., Shao, C., Cao, K., et al. (2022) Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Cancer Imaging, 22, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[22] Zeng, P., Qu, C., Liu, J., Cui, J., Liu, X., Xiu, D., et al. (2022) Comparison of MRI and CT-Based Radiomics for Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Acta Radiologica, 64, 2221-2228. [Google Scholar] [CrossRef] [PubMed]
[23] Shi, S., Lin, C., Zhou, J., Wei, L., chen, M., Zhang, J., et al. (2024) Development and Validation of a Deep Learning Radiomics Model with Clinical-Radiological Characteristics for the Identification of Occult Peritoneal Metastases in Patients with Pancreatic Ductal Adenocarcinoma. International Journal of Surgery, 110, 2669-2678. [Google Scholar] [CrossRef] [PubMed]
[24] Zhang, T., Dong, X., Zhou, Y., Liu, M., Hang, J. and Wu, L. (2021) Development and Validation of a Radiomics Nomogram to Discriminate Advanced Pancreatic Cancer with Liver Metastases or Other Metastatic Patterns. Cancer Biomarkers, 32, 541-550. [Google Scholar] [CrossRef] [PubMed]
[25] König, A., Gros, H., Hinz, U., Hank, T., Kaiser, J., Hackert, T., et al. (2022) Refined Prognostic Staging for Resected Pancreatic Cancer by Modified Stage Grouping and Addition of Tumour Grade. European Journal of Surgical Oncology, 48, 113-120. [Google Scholar] [CrossRef] [PubMed]
[26] Nurmi, A., Mustonen, H., Parviainen, H., Peltola, K., Haglund, C. and Seppänen, H. (2017) Neoadjuvant Therapy Offers Longer Survival than Upfront Surgery for Poorly Differentiated and Higher Stage Pancreatic Cancer. Acta Oncologica, 57, 799-806. [Google Scholar] [CrossRef] [PubMed]
[27] Cen, C., Wang, C., Wang, S., Wen, K., Liu, L., Li, X., et al. (2023) Clinical-radiomics Nomogram Using Contrast-Enhanced CT to Predict Histological Grade and Survival in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology, 13, Article 1218128. [Google Scholar] [CrossRef] [PubMed]
[28] Liao, H., Li, Y., Yang, Y., Liu, H., Zhang, J., Liang, H., et al. (2022) Comparison of Multiple Radiomics Models for Identifying Histological Grade of Pancreatic Ductal Adenocarcinoma Preoperatively Based on Multiphasic Contrast-Enhanced Computed Tomography: A Two-Center Study in Southwest China. Diagnostics, 12, Article 1915. [Google Scholar] [CrossRef] [PubMed]
[29] Myoteri, D., Dellaportas, D., Lykoudis, P.M., Apostolopoulos, A., Marinis, A. and Zizi-Sermpetzoglou, A. (2017) Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma. Gastroenterology Research and Practice, 2017, Article ID: 9207616. [Google Scholar] [CrossRef] [PubMed]
[30] Li, Q., Song, Z., Li, X., Zhang, D., Yu, J., Li, Z., et al. (2023) Development of a CT Radiomics Nomogram for Preoperative Prediction of Ki-67 Index in Pancreatic Ductal Adenocarcinoma: A Two-Center Retrospective Study. European Radiology, 34, 2934-2943. [Google Scholar] [CrossRef] [PubMed]
[31] Li, Q., Yu, J., Zhang, H., Meng, Y., Liu, Y.F., Jiang, H., et al. (2022) Prediction of Tumor-Infiltrating CD20+ B-Cells in Patients with Pancreatic Ductal Adenocarcinoma Using a Multilayer Perceptron Network Classifier Based on Non-Contrast MRI. Academic Radiology, 29, e167-e177. [Google Scholar] [CrossRef] [PubMed]
[32] Smeets, E.M.M., Trajkovic-Arsic, M., Geijs, D., Karakaya, S., van Zanten, M., Brosens, L.A.A., et al. (2024) Histology-based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer. Journal of Nuclear Medicine, 65, 1151-1159. [Google Scholar] [CrossRef] [PubMed]
[33] Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L.H., Mandrekar, S., et al. (2017) iRECIST: Guidelines for Response Criteria for Use in Trials Testing Immunotherapeutics. The Lancet Oncology, 18, e143-e152. [Google Scholar] [CrossRef] [PubMed]
[34] Katz, M.H.G., Fleming, J.B., Bhosale, P., Varadhachary, G., Lee, J.E., Wolff, R., et al. (2012) Response of Borderline Resectable Pancreatic Cancer to Neoadjuvant Therapy Is Not Reflected by Radiographic Indicators. Cancer, 118, 5749-5756. [Google Scholar] [CrossRef] [PubMed]
[35] Ikuta, S., Aihara, T., Nakajima, T. and Yamanaka, N. (2024) Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemotherapy Computed Tomography Radiomics. Cureus, 16, e52193. [Google Scholar] [CrossRef] [PubMed]
[36] Borhani, A.A., Dewan, R., Furlan, A., Seiser, N., Zureikat, A.H., Singhi, A.D., et al. (2020) Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma. American Journal of Roentgenology, 214, 362-369. [Google Scholar] [CrossRef] [PubMed]
[37] Gregucci, F., Fiorentino, A., Mazzola, R., Ricchetti, F., Bonaparte, I., Surgo, A., et al. (2021) Radiomic Analysis to Predict Local Response in Locally Advanced Pancreatic Cancer Treated with Stereotactic Body Radiation Therapy. La radiologia Medica, 127, 100-107. [Google Scholar] [CrossRef] [PubMed]
[38] Simpson, G., Spieler, B., Dogan, N., Portelance, L., Mellon, E.A., Kwon, D., et al. (2020) Predictive Value of 0.35 T Magnetic Resonance Imaging Radiomic Features in Stereotactic Ablative Body Radiotherapy of Pancreatic Cancer: A Pilot Study. Medical Physics, 47, 3682-3690. [Google Scholar] [CrossRef] [PubMed]
[39] Park, S., Sham, J.G., Kawamoto, S., Blair, A.B., Rozich, N., Fouladi, D.F., et al. (2021) CT Radiomics-Based Preoperative Survival Prediction in Patients with Pancreatic Ductal Adenocarcinoma. American Journal of Roentgenology, 217, 1104-1112. [Google Scholar] [CrossRef] [PubMed]
[40] Yoo, J., Hyun, S.H., Lee, J., Cheon, M., Lee, K.H., Heo, J.S., et al. (2024) Prognostic Significance of 18F-FDG PET/CT Radiomics in Patients with Resectable Pancreatic Ductal Adenocarcinoma Undergoing Curative Surgery. Clinical Nuclear Medicine, 49, 909-916. [Google Scholar] [CrossRef] [PubMed]
[41] Parr, E., Du, Q., Zhang, C., Lin, C., Kamal, A., McAlister, J., et al. (2020) Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy. Cancers, 12, Article 1051. [Google Scholar] [CrossRef] [PubMed]
[42] Shao, C., Zhang, J., Guo, J., Zhang, L., Zhang, Y., Ma, L., et al. (2023) A Radiomics Nomogram Model for Predicting Prognosis of Pancreatic Ductal Adenocarcinoma after High-Intensity Focused Ultrasound Surgery. International Journal of Hyperthermia, 40, Article ID: 2184397. [Google Scholar] [CrossRef] [PubMed]
[43] Lambin, P., Leijenaar, R.T.H., Deist, T.M., Peerlings, J., de Jong, E.E.C., van Timmeren, J., et al. (2017) Radiomics: The Bridge between Medical Imaging and Personalized Medicine. Nature Reviews Clinical Oncology, 14, 749-762. [Google Scholar] [CrossRef] [PubMed]

为你推荐